About
Visioneering Technologies Inc. (VTI) is a medical device company based in Alpharetta, Georgia, specializing in advanced contact lenses for eye care conditions like presbyopia, myopia, and astigmatism. Founded in 2006, VTI combines expertise in clinical research, engineering, and regulatory compliance to create innovative ophthalmic solutions. The company's flagship product, the NaturalVue® Multifocal 1 Day contact lens, utilizes proprietary NeuroFocus Optics technology. This lens offers improved vision at all distances and helps slow the progression of myopia, making it suitable for both adults with presbyopia and children with myopia. VTI's products are marketed across North America, Europe, Australia, and are expanding into Asia, targeting regions with high demand for vision correction solutions. VTI is led by a team of experienced professionals, including CEO Dr. Juan Carlos Aragon and Chief Medical Officer Dr. Kuang-Mon Tuan. The company is publicly traded on the Australian Securities Exchange under the ticker symbol VTI.
Technologies
Keywords
Company Information
-
Employees 26
-
Founded 2008
-
Annual Revenue $8670000
Location
10745 Westside Way, Alpharetta, Georgia, United States, 30009